Respiratory effects induced by occupational exposure to refractory ceramic fibers

Refractory ceramic fibers (RCFs) are increasingly used as heating-insulated materials in various industries. However, toxicological and epidemiological studies focusing on the adverse effects of RCFs were still insufficient, particularly in China. We conducted a cross-sectional study to evaluate comprehensively the associations between occupational exposure to RCFs and respiratory health effects among Chinese workers. We measured and calculated cumulative RCFexposure levels of RCFs workers from the biggest RCFs factory in China. In total, 430 RCF-exposed workers and 121 controls were enrolled in this study. Physical examinations of the respiratory system were performed and serum levels of biomarkers including Clara cell protein 16 (CC16), surfactant protein D (SP-D), transforming growth factor beta 1 (TGF-beta 1), and 8-hydroxy-2 '-deoxyguanosine (8-OHdG) were determined among all subjects. RCF exposure workers showed a higher prevalence rate of respiratory symptoms (cough: 11.9%) and lower levels of small airways function indices (V-50%: 82.71 +/- 20.01, maximal mid expiratory flow (MMEF)%: 81.08 +/- 19.56) compared with the control group (cough: 5.0%, V-50%: 90.64 +/- 24.36, MMEF%: 88.83 +/- 24.22). RCFs workers showed higher levels of TGF-beta 1 (31.04 ng/mL) and 8-OHdG (130.72 ng/mL) and lower levels of CC16 (3.68 ng/mL) compared with the controls (TGF-beta 1: 26.63 ng/mL, 8-OHdG: 106.86 ng/mL, CC16: 5.65 ng/mL). After adjusting for covariates, cumulative RCF exposure levels showed significant positive associations with the levels of TGF-beta 1 and 8-OHdG and negative association with the level of CC16. Occupational RCF exposure could induce adverse respiratory health effects, including cough and small airways damage, which may correlate to the altered levels of lung damage markers (CC16 and TGF-beta 1) and oxidative markers (8-OHdG).

Automated summary

The study found that workers exposed to RCFs are more likely to experience respiratory symptoms and decline in small airway function, with significant alterations in lung damage markers and oxidative markers.